Cargando…

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer

BACKGROUND: The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate. METHODS: We studied the rate of occurrence of sentinel lymph node metastasis in 255 breast cancer patients with pure DCIS showing no invasive components on routine p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Keiichiro, Ogiya, Akiko, Kimura, Kiyomi, Morizono, Hidetomo, Iijima, Kotaro, Miyagi, Yumi, Nishimura, Seiichiro, Makita, Masujiro, Horii, Rie, Akiyama, Futoshi, Iwase, Takuji
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837658/ https://www.ncbi.nlm.nih.gov/pubmed/20105298 http://dx.doi.org/10.1186/1477-7819-8-6

Ejemplares similares

Skin invasion and prognosis in node negative breast cancer: a retrospective study
por: Tada, Keiichiro, et al.
Publicado: (2008)

Clear Cell Sarcoma of the Neck Which Metastasized to the Mammary Gland
por: Fukada, Ippei, et al.
Publicado: (2013)

Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in Stage I Breast cancer patients
por: Mori, Miki, et al.
Publicado: (2006)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients
por: Makita, Masujiro, et al.
Publicado: (2015)

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence
por: Sato, Ayaka, et al.
Publicado: (2019)

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities
por: Izumori, Ayumi, et al.
Publicado: (2019)

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
por: Osako, Tomo, et al.
Publicado: (2014)

Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan
por: Tozaki, Mitsuhiro, et al.
Publicado: (2017)

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
por: Fukuda, Takayo, et al.
Publicado: (2016)

Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations
por: Izumori, Ayumi, et al.
Publicado: (2011)

Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
por: Maeshima, Yurina, et al.
Publicado: (2021)

Clinical Significance of Female-hormones and Cytokines in Breast Cancer Patients Complicated with Aromatase Inhibitor-related Osteoarthropathy - Efficacy of Vitamin E
por: Kiyomi, Anna, et al.
Publicado: (2015)

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay
por: Osako, T, et al.
Publicado: (2012)

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
por: Honma, Naoko, et al.
Publicado: (2015)

Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients
por: Kiyomi, Anna, et al.
Publicado: (2015)

Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis
por: Shimazu, Kenzo, et al.
Publicado: (2018)

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
por: Fukada, Ippei, et al.
Publicado: (2017)

Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis
por: Inari, Hitoshi, et al.
Publicado: (2020)

Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy
por: Inari, Hitoshi, et al.
Publicado: (2020)

Microarray analysis of ductal carcinoma in situ samples obtained by puncture from surgical resection specimens
por: Jikuzono, Tomoo, et al.
Publicado: (2021)

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy
por: Abe, Tomomi, et al.
Publicado: (2017)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer
por: Makita, Masujiro, et al.
Publicado: (2020)

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients
por: Osako, Tomo, et al.
Publicado: (2017)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)

Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?
por: Al-Shurbasi, Nour, et al.
Publicado: (2021)

Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer
por: Teruya, Natsuki, et al.
Publicado: (2023)

Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
por: Abe, Shinya, et al.
Publicado: (2015)

Label‐free multiphoton excitation imaging as a promising diagnostic tool for breast cancer
por: Matsui, Takahiro, et al.
Publicado: (2022)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review
por: Yokoe, Takamichi, et al.
Publicado: (2017)

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era
por: Nakajima, Naomi, et al.
Publicado: (2018)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Hung, Peiyin, et al.
Publicado: (2019)

De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ
por: Abdulla, Hussain A, et al.
Publicado: (2023)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

Mental Health and Related Factors after the Great East Japan Earthquake and Tsunami
por: Yokoyama, Yukari, et al.
Publicado: (2014)

Virtual Touch tissue quantification cannot assess breast cancer lesions except for ductal carcinomas in situ and small invasive cancers: a retrospective study
por: Tada, Keiichiro, et al.
Publicado: (2015)

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer
por: Miyoshi, Yuichiro, et al.
Publicado: (2019)

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
por: Killelea, Brigid K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3t5hjandl8rvtp82j9k0dfapga